Health ❯Healthcare ❯Medical Research

Cancer Research

Immunotherapy Breast Cancer Prostate Cancer Colorectal Cancer Glioblastoma Pancreatic Cancer Multiple Myeloma Tumor Microenvironment Cancer Immunotherapy Skin Cancer

NF1-Low ER+ Breast Cancers Identified as Likely Responders to CDK4/6 Inhibitors

Prospective validation and reliable NF1 protein tests are needed before the biomarker can guide prescribing.

Johns Hopkins CSF-BAM Detects Brain Cancers With High Accuracy

Forskolin Shows Dual-Action Promise Against KMT2A‑Rearranged AML in Preclinical Study

Study Reveals Tamoxifen Triggers PI3K Pathway Linked to Uterine Cancer

AI Flags Cancer Signs Missed in Routine Prostate Biopsies in Over 80% of Cases

MD Anderson Debuts PreCiSE, a Genome-Wide CRISPR Platform for Primary NK Cells

Paclitaxel Reengineered Into Self-Assembling Nanovesicle Shows Strong Preclinical Gains

Tumor-Induced Nerve Injury Identified as Driver of Anti–PD-1 Resistance

First Targeted Treatment Eliminates Rare T-Cell Lymphoma After CAR T

Everolimus Plus Carboplatin Delays Progression in Advanced Triple-Negative Breast Cancer, Phase 2 Study Shows

HPV16 Co-opts IL-23 to Thwart T Cells, USC Study Finds

KRAS-Targeted Vaccine Shows Robust Immune Response, Longer-Than-Expected Survival in Pancreatic and Colorectal Cancer Trial

TIM‑3 Triplet Therapy Shows Promise in Immunotherapy‑Resistant Melanoma Models

JNK Pathway Loss Drives Resistance to Endocrine and CDK4/6 Treatment in ER+ Breast Cancer

Bacteria-Shielded Virus Platform Clears Tumors in Mice

Intratumoral Fc-Optimized CD40 Antibody Achieves Systemic Remissions in Phase 1 Study

AI-Informed Pipeline Accelerates Bi-Specific CAR-T Design and Clears Tumors in Mice

mRNA Neoantigen Vaccine Amplifies Anti-PD-1 Immunity and Suppresses Gastric Cancer Spread in Mice

Off-The-Shelf KRAS Vaccine Yields Robust T-Cell Responses and Survival Benefit

SWIFT-seq Blood Test Enables Non-Invasive Comprehensive Profiling of Multiple Myeloma